for in Biological Technology
Navigation Links
for in Biological Technology
DOE awards $377 million in funding for 46 energy frontier research centers
Washington, DC In a major effort to accelerate the scientific breakthroughs needed to build a new 21st-century energy economy, U.S. Energy Secretary Steven Chu announced the delivery of $377 million in funding for 46 new multi-million-dollar Energy Frontier Research Centers (EFRCs) located at uni...Microbix Sales Grow 22% For Nine Months
Burn rate significantly reduced and Semen Sexing Technology achieves milestone TORONTO, Aug. 6 /PRNewswire-FirstCall/ - For nine months ended June 30, 2009, Microbix Biosystems Inc. (TSX:MBX) announced strong sales and a significantly reduced burn rate. The third quarter had a small...REDWOOD CITY, Calif.,, Aug. 6 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the publication in Cell Stem Cell of data demonstrating potent anti-cancer activity in colon ...
UMEA, Sweden, August 6 /PRNewswire/ -- Omnio Healer AB, a pioneer company developing novel therapies for wound healing and anti-infection, today announced that it has entered into a partnership agreement with Eden Biodesign. Under the agreement Eden Biodesign will provide process development a...
VANCOUVER, Aug. 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced its financial results for the second quarter ended June 30, 2009. "We were pleased to observe continued sales growth in our Proprietary Medical Products business during the quar...
SEATTLE, Aug. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today reported recent achievements and financial results for the second quarter and six months ended June 30, 2009. "The second quarter of 2009 was a transforming quarter for the Co...
NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
SAN MATEO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that the United States Food and Drug Administration (FDA) has extended the Pr...Next Safety Releases Advanced Respirator for Infectious Diseases
JEFFERSON, N.C., Aug. 5 /PRNewswire/ -- Next Safety, Inc. (NSI) announces advanced respirators that give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to the public respirator products the company developed for the bird flu influenza A ...BETHESDA, Md. and BRIDGEWATER, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Today, the Foundation for the National Institutes of Health and sanofi-aventis announced an unprecedented donation by the global pharmaceutical leader providing approximately $1.3 million in pharmaceutical th...
NEW HAVEN, Conn., Aug. 5 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive res...
Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient
ASL Pharmacy® announces the availability of Compounded Mupirocin Liquid. Mupirocin is typically only found in ointment form. ASL's compound does not contain any added ingredients, only pure mupirocin, sterile water and sterile saline. This is significant because ASL serves patients with chron...SAN FRANCISCO, Aug. 4 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused on the development of novel therapeutics for heart failure patients, today announced dosing of its first patient in a Phase 2 clinical study of its lead product, CD-NP, for the treatme...
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
VENLO, The Netherlands, Aug. 4 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN ) today announced the Webcast of its second quarter 2009 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 11, and will include remarks by Peer M. Schatz, President ...VANCOUVER, Aug. 4 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced the launch of a series of new, proprietary Quill(TM) SRS product codes specifically designed for laparoscopic, or minimally invasive, gynecology procedures, including hysterectomi...
Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
MINNEAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended June 30, 2009 decreased 6.9% to $25.4 million or $.68 per diluted share compared with $27.3 million or $.70 per diluted share for the quarter ended June 30...PRINCETON, N.J., Aug. 4 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc., (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted Or...
Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
CRANBURY, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN ) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/694,260, titled "Cyclic Natriuretic Peptide Constructs...New Director of Lab Sales for Polymathic Analytical Labs
ORANGEBURG, S.C., Aug. 4 /PRNewswire/ -- Polymathic Analytical Labs, a Zeus company, announces that William J. Kerr will assume the role of Director of Laboratory Sales. With more than 40 years of polymer experience, Polymathic Analytical Labs' core business is the specialized and routine tes...Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers received their first shot of the vaccine and, during the thr...Rapid heating prepares energy-saving zeolite for greater role in industrial separations
Thin-film zeolite membranes with tiny, molecule-sized pores are one step closer to replacing the energy-intensive processes now used in industrial separations, a group of academic researchers is reporting. Writing this week in Science magazine, the group says the membranes' ability to separat...BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has received Orphan Drug Designation from the Europ...
Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today that the clinical trial of its A/H1N1 influenza vaccine is proceeding well. All of the volunteers have received their first shot of the vaccine and, during th...NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE-Amex: NBY ) today announced that Roy J. Wu has joined the company as senior vice president for business development. Wu brings to NovaBay more than 30 years of highly successful experience in the p...QUEBEC CITY, Aug. 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), its partner and licensee for perifosi...
Hoya Announces First Quarter Financial Results for FY2010
TOKYO, Japan, August 3 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the first quarter ended June 30, 2009. Net sales were 94.9 billion yen for the quarter, a 27.0% decrease from 130.1 billion yen in the same period last year, and operating income was 9.2 bil...Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its Inclinicalperform application. Inclinicalperform is software-as-a-...
CHICAGO, July 31 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that it received a complete response letter today from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Restanza(TM) (cethrom...
SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009, after the close of U.S.-based financial markets. Howard Robin, president and chief execut...
China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
SHANGHAI, July 31 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it has submitted applicatio...Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
NEW BRUNSWICK, N.J., July 30 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced that, on July 29, 2009, the Company entered into definitive purchase agreements with certain members of Senesco's Board of Directors a...Trubion Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call
SEATTLE, July 30 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced that it plans to issue earnings results for its second quarter and six months ended June 30, 2009, after the close of market on Aug. 6, 2009. The company's earnings conference call w...FT. LAUDERDALE, Fla., July 30 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a growing US Clinical Research Organization (CRO) has selected OmniComm to pr...
RALEIGH, N.C. , July 30 /PRNewswire/ -- SmartGene, Inc., a provider of novel services for the management and analysis of genetic data, today announced that it has entered into an agreement under which The Johns Hopkins Hospital will utilize SmartGene's advanced technology and integrated...
SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009
SAN DIEGO, CA, July 30, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ) will release its second quarter 2009 financial results on Tuesday, August 4, 2009 before the opening of the U.S. financial markets. The Company will also host a conference call with a live Internet bro...Sunesis Receives Approval for Listing on The NASDAQ Capital Market
SOUTH SAN FRANCISCO, Calif., July 30 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced th...Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
IRVINE, Calif., July 30 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a market leader in laser transmyocardial revascularization (TMR), today announced that it has submitted a pre-IDE (Investigational Device Exemption) to the Food and Drug Administrat...Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced its financial results for the three and six months ended June 30, 2009. Financial Highlights Adjusted diluted EPS, which excludes the impact of certain purchase acc...LAUSANNE, Switzerland and MEDFORD, Massachussets, July 30 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and MSM Protein Technologies (MSM), a human ...
Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up
Aztech Controls, an expert in chemical and gas handling has developed a standard gas stick that can be shipped from stock greatly minimizing lead times for Semiconductor tool installations. (PRWEB) July 30, 2009 -- Aztech Controls ( http://www.aztechcontrols.com ), a Ch...NIST scientists study how to stack the deck for organic solar power
A new class of economically viable solar power cellscheap, flexible and easy to makehas come a step closer to reality as a result of recent work* at the National Institute of Standards and Technology (NIST), where scientists have deepened their understanding of the complex organic films at the hea...Other TagsratchetAlgaAlgaKochAmesAmesAmesAnusOther Contentsshortshortshortshortshortshortshortshortshortshortshellshellshellshellshellshellmethodmethodmethodmethodmethodmethodmethodmethodmethodmethodshotgunshotgunshotgunshuttleshuttleshuttleshuttletubestubestubestubestubestubestubestubestubessieve
ratchetdinucleotideAveryAlgaKochbisphosphateSpemannHansreuptakeMalthusdiphosphateAmesdeterminantAnus
(Date:12/2/2009)..., before the thought telling it to flex can race d... ion channelmust open in the surface of each cell ...t spur the cell to action. New research* at the Na...) has allowed scientists to observe ion channels w...entially offering insights for future drug develop...
(Date:12/2/2009)...g to the National Institute of Health, 40 percent ... already have some stage of diabetic retinopathy. ... by leaky blood vessels, is a major cause of blind...t feared diabetic complications. In fact, up to 8...10 years or more will experience some form of diab...
(Date:12/1/2009)...rve cell degeneration plays a crucial role. In the...erived from steering the generation and/or migrati...n the current issue of the renowned journal Natur...genesis the process of nerve cell development wa...The textbooks asserted that dead nerve cells could...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New source discovered for the generation of nerve cells in the brain 2Great wines come from great soils 10624 1Great wines come from great soils 10624 2TeamStaff Announces Revised Business Strategy 3B Chief Executive Officer to Step Down on Completion of Search For Successor 60649 1TeamStaff Announces Revised Business Strategy 3B Chief Executive Officer to Step Down on Completion of Search For Successor 60649 2TeamStaff Announces Revised Business Strategy 3B Chief Executive Officer to Step Down on Completion of Search For Successor 60649 3Department of Health Confirms Pennsylvanias First Pediatric Death Associated with H1N1 Flu 60644 1Department of Health Confirms Pennsylvanias First Pediatric Death Associated with H1N1 Flu 60644 2(Date:12/2/2009)...lifornia Institute of Technology (Caltech) have be... the previously mysterious process by which long c...nzymes called ubiquitin ligases to proteins that c... proteins for destruction by protein-degrading com...igases build ubiquitin chains very rapidly by tran...
(Date:12/2/2009)...ate-specific antigen (PSA) value of less than or e...tion therapy (EBRT) are less likely to have a canc...to a study in the December 1 issue of the Internat...s, the official journal of the American Society fo...rostate cancer patient are monitored after a patie...
(Date:12/2/2009)...nt therapy (CIMT) is a potentially effective form ...ral palsy, but more research is needed, according ...er issue of Physical Therapy (PTJ), the scientif...ation (APTA). The review, which analyzed 21 interv... that further research should focus on the frequen...
(Date:12/2/2009)...been a top name in the medical supply industry sin...professional staff, and a keen understanding of th...tablished itself as a provider of ground ambulance...upplies distributor. The distinguished history of ...xt phase with the redesign and launch of its websi...
(Date:12/2/2009)...ies to increase awareness of prostate cancer and e... early detection , Denver...ies, friends and neighbors – at all fitness ...udolph Ramble 5K. The Rudolph Ramble 5K is a part...nched by the Prostate Conditions Education Counci...
Breaking Medicine News(10 mins):Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4[1] Caltech scientists show how ubiquitin chains are added to cell-cycle proteins[0] PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients[0] Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy[0] From A to B and Everything In-between; AB First Aid Launch New Web Storefront[0] PACE Race Returns with Denver's Rudolph Ramble
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |